ArticleBritish journal of pharmacology2020

Metabolic reprogramming by N-acetyl-seryl-aspartyl-lysyl-proline protects against diabetic kidney disease.

Swayam Prakash Srivastava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.